Keywords: amylin, shares, drop, pramlintide, data, california, usa-based

Amylin Shares Drop On Pramlintide Data

Article | 22 August 1997

Print This

Shares in California, USA-based Amylin Pharmaceuticals recently tumbled43% to $8.47 on news that a Phase III trial of its antidiabetes drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in